Metastatic melanoma response to combination therapy with BRAF and MEK inhibitors: a FDG PET/CT pilot study

被引：0
|
作者：
Burroni, L.
Fringuelli, F.
Biscontini, G.
Palucci, A.
机构：
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2019年 / 46卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0446
引用
收藏
页码：S586 / S587
页数：2
相关论文
共 50 条
  • [31] Prolonged survival of a patient with brain melanoma metastasis treated with BRAF and MEK inhibitors combination therapy
    Spallone, Giulia
    Garofalo, Virginia
    Picchi, Eliseo
    Pitocco, Rossella
    Bianchi, Federico
    Ventura, Alessandra
    Santoni, Riccardo
    Bianchi, Luca
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2020, 155 (02): : 245 - 247
  • [32] Immunomodulatory effects of BRAF and MEK inhibitors: Implications for Melanoma therapy
    Kuske, Marvin
    Westphal, Dana
    Wehner, Rebekka
    Schmitz, Marc
    Beissert, Stefan
    Praetorius, Christian
    Meier, Friedegund
    PHARMACOLOGICAL RESEARCH, 2018, 136 : 151 - 159
  • [33] Use of proton pump inhibitors in people taking BRAF/MEK inhibitors for metastatic melanoma
    不详
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188 (04) : E29 - E29
  • [34] Cutaneous reactions in children treated with MEK inhibitors, BRAF inhibitors, or combination therapy: A multicenter study
    Boull, Christina L.
    Gardeen, Samantha
    Abdali, Talal
    Li, Edward
    Potts, Jolee
    Rubin, Nathan
    Carlberg, Valerie M.
    Gupta, Deepti
    Hunt, Raegan
    Luu, Minnelly
    Maguiness, Sheilagh M.
    Moertel, Christopher L.
    Song, Hannah
    Vivar, Karina L.
    Coughlin, Carrie
    Huang, Jennifer T.
    Lara-Corrales, Irene
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 84 (06) : 1554 - 1561
  • [35] Cutaneous Toxic Effects of BRAF Inhibitors Alone and in Combination With MEK Inhibitors forMetastatic Melanoma
    Carlos, Giuliana
    Anforth, Rachael
    Clements, Arthur
    Menzies, Alexander M.
    Carlino, Matteo S.
    Chou, Shaun
    Fernandez-Penas, Pablo
    JAMA DERMATOLOGY, 2015, 151 (10) : 1103 - 1109
  • [36] Patterns of progression in metastatic melanoma patients treated with Braf and Mek inhibitors: an Italian Melanoma Intergroup (IMI) study
    Marconcini, R.
    Marra, E.
    De Rosa, F.
    Stucci, L. S.
    Orgiano, L.
    Ribero, S.
    Bloise, F.
    Antonuzzo, A.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2017, 28
  • [37] Metastatic melanoma patients treated with Braf and Mek inhibitors: Patterns of progression. An Italian Melanoma Intergroup study
    Marconcini, R.
    Marra, E.
    De Rosa, F.
    Stucci, S. L.
    Orgiano, L.
    Ribero, S.
    Bloise, F.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2017, 28 : 63 - 64
  • [38] Unusual association of BRAF and MEK inhibitors: Clinical response of metastatic melanoma treated with dabrafenib- cobimetinib
    Leenhardt, Fanny
    Mbatchi, Litaty
    Evrard, Alexandre
    Cupissol, Didier
    Lesage, Candice
    BULLETIN DU CANCER, 2023, 110 (7-8) : 865 - 868
  • [39] New insights on the management of cutaneous adverse events of BRAF and MEK inhibitors alone and in combination used in metastatic melanoma
    Makris, N.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 : 67 - 67
  • [40] Efficient treatment of a metastatic melanoma patient with a combination of BRAF and MEK inhibitors based on circulating tumor DNA analysis
    Peuvrel, L.
    Denis, M.
    Herbreteau, G.
    Knol, A. -C.
    Vallee, A.
    Khammari, A.
    Theoleyre, S.
    Saint-Jean, M.
    Dreno, B.
    Quereux, G.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 : 74 - 74
12345